Therapeutic use of psilocybin: Practical considerations for dosing and administration

被引:36
作者
MacCallum, Caroline A. [1 ]
Lo, Lindsay A. [2 ]
Pistawka, Carly A. [3 ]
Deol, Jagpaul Kaur [4 ]
机构
[1] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC, Canada
[2] Univ Toronto, Dalla Lana Sch Publ Hlth, Dept Publ Hlth Sci, Toronto, ON, Canada
[3] Univ British Columbia, Fac Sci, Vancouver, BC, Canada
[4] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
来源
FRONTIERS IN PSYCHIATRY | 2022年 / 13卷
关键词
psilocybin; psilocybin-assisted psychotherapy; psychedelics; psilocin; magic mushrooms; patient safety; 5-HT2A RECEPTOR FUNCTION; LIFE-THREATENING CANCER; PSYCHEDELIC DRUGS; PSYCHOACTIVE TRYPTAMINES; DEPRESSION; ANXIETY; ANTIDEPRESSANTS; GUIDELINES; INHIBITORS; LSD;
D O I
10.3389/fpsyt.2022.1040217
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The interest in psilocybin as a therapeutic approach has grown exponentially in recent years. Despite increasing access, there remains a lack of practical guidance on the topic for health care professionals. This is particularly concerning given the medical complexity and vulnerable nature of patients for whom psilocybin-assisted psychotherapy may be considered. This article aims to provide health care professionals with an overview of practical considerations for psilocybin therapy, rooted in a patient safety focus. Within this piece we will review basic psilocybin pharmacology and pharmacokinetics, indications, practical therapeutic strategies (e.g., dosing, administration, monitoring) and safety considerations (e.g., contraindications, adverse events, and drug interactions). With this information, our goal is to increase the knowledge and comfort of health care professionals to discuss and counsel their patients on psilocybin therapy, ultimately improving patient care and safety.
引用
收藏
页数:8
相关论文
共 73 条
  • [1] Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study
    Anderson, Brian T.
    Danforth, Alicia
    Daroff, Robert
    Stauffer, Christopher
    Ekman, Eve
    Agin-Liebes, Gabrielle
    Trope, Alexander
    Boden, Matthew Tyler
    Dilley, James
    Mitchell, Jennifer
    Woolley, Joshua
    [J]. ECLINICALMEDICINE, 2020, 27
  • [2] [Anonymous], 2022, Canada Gazette, V156
  • [3] Blood Brain-Derived Neurotrophic Factor (BDNF) and Major Depression: Do We Have a Translational Perspective?
    Arosio, Beatrice
    Guerini, Franca Rosa
    Voshaar, Richard C. Oude
    Aprahamian, Ivan
    [J]. FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2021, 15
  • [4] Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists
    Batman, AM
    Munzar, P
    Beardsley, PM
    [J]. PSYCHOPHARMACOLOGY, 2005, 179 (02) : 393 - 401
  • [5] Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects
    Becker, Anna M.
    Holze, Friederike
    Grandinetti, Tanja
    Klaiber, Aaron
    Toedtli, Vanja E.
    Kolaczynska, Karolina E.
    Duthaler, Urs
    Varghese, Nimmy
    Eckert, Anne
    Grunblatt, Edna
    Liechti, Matthias E.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (04) : 886 - 895
  • [6] Automated design of ligands to polypharmacological profiles
    Besnard, Jeremy
    Ruda, Gian Filippo
    Setola, Vincent
    Abecassis, Keren
    Rodriguiz, Ramona M.
    Huang, Xi-Ping
    Norval, Suzanne
    Sassano, Maria F.
    Shin, Antony I.
    Webster, Lauren A.
    Simeons, Frederick R. C.
    Stojanovski, Laste
    Prat, Annik
    Seidah, Nabil G.
    Constam, Daniel B.
    Bickerton, G. Richard
    Read, Kevin D.
    Wetsel, William C.
    Gilbert, Ian H.
    Roth, Bryan L.
    Hopkins, Andrew L.
    [J]. NATURE, 2012, 492 (7428) : 215 - +
  • [7] PSILOCYBIN AND PSILOCIN LEVELS IN 20 SPECIES FROM 7 GENERA OF WILD MUSHROOMS IN THE PACIFIC NORTHWEST, USA
    BEUG, MW
    BIGWOOD, J
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 1982, 5 (03) : 271 - 285
  • [8] VARIATION OF PSILOCYBIN AND PSILOCIN LEVELS WITH REPEATED FLUSHES (HARVESTS) OF MATURE SPOROCARPS OF PSILOCYBE-CUBENSIS (EARLE) SINGER
    BIGWOOD, J
    BEUG, MW
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 1982, 5 (03) : 287 - 291
  • [9] Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes
    Blough, Bruce E.
    Landavazo, Antonio
    Decker, Ann M.
    Partilla, John S.
    Baumann, Michael H.
    Rothman, Richard B.
    [J]. PSYCHOPHARMACOLOGY, 2014, 231 (21) : 4135 - 4144
  • [10] Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder A Randomized Clinical Trial
    Bogenschutz, Michael P.
    Ross, Stephen
    Bhatt, Snehal
    Baron, Tara
    Forcehimes, Alyssa A.
    Laska, Eugene
    Mennenga, Sarah E.
    O'Donnell, Kelley
    Owens, Lindsey T.
    Podrebarac, Samantha
    Rotrosen, John
    Tonigan, J. Scott
    Worth, Lindsay
    [J]. JAMA PSYCHIATRY, 2022, 79 (10) : 953 - 962